Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer.
Rachael Elizabeth CliffordN GovindarajahJ L ParsonsS GollinsN P WestD VimalachandranPublished in: The British journal of surgery (2019)
Despite extensive research and promising preclinical studies, a definite further agent in addition to fluoropyrimidines that consistently improves response rate has yet to be found.